Contact usWorldwide
HomeAbout RosettaOur ScienceCareers
 

Archived Publications
Genetic Selection of Peptide Inhibitors of Biological Pathways.

Science 285:591-595 (1999).

(Note: Current Rosetta Inpharmatics employees are shown in boldface type.)

T. C. Norman, D. L. Smith, P. K. Sorger, B. L. Drees, S. M. O'Rourke, Timothy R. Hughes, Christopher J. Roberts, Stephen H. Friend, S. Fields, and A. W. Murray.

Abstract

Genetic selections were used to find peptides that inhibit biological pathways in budding yeast. The peptides were presented inside cells as peptamers, surface loops on a highly expressed and biologically inert carrier protein, a catalytically inactive derivative of staphylococcal nuclease. Peptamers that inhibited the pheromone signaling pathway, transcriptional silencing, and the spindle checkpoint were isolated. Putative targets for the inhibitors were identified by a combination of two-hybrid analysis and genetic dissection of the target pathways. This analysis identified Ydr517w as a component of the spindle checkpoint and reinforced earlier indications that Ste50 has both positive and negative roles in pheromone signaling. Analysis of transcript arrays showed that the peptamers were highly specific in their effects, which suggests that they may be useful reagents in organisms that lack sophisticated genetics as well as for identifying components of existing biological pathways that are potential targets for drug discovery.

Science is available online


Printer Friendly Page
 

Publications Archive

Abstracts to publications by Rosetta Inpharmatics employees are available below Learn more
 
Site Map Privacy Policy - Opens New Window Trademarks - Opens New Window Terms of Use - Opens New Window Copyright © 2004-2007 Rosetta Inpharmatics LLC. - Opens New Window Merck & Co., Inc. (USA) - Opens New Window